Markus Warmuth

Insider Reports History

Location
Boston, MA
Signature
/s/ Markus Warmuth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Markus Warmuth:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. President & CEO, Director Common Stock 618,937 $15,209,510 $24.57 07 Jan 2026 Direct
Monte Rosa Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 406,000 02 Jan 2026 Direct

Insider Reports Filed by Markus Warmuth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 07 Jan 2026 3 -$128,373 4 President & CEO, Director 09 Jan 2026, 16:05
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2026 3 -$153,748 4 President & CEO, Director 05 Jan 2026, 16:04
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2025 2 $0 4 President & CEO, Director 06 Jan 2025, 16:15
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2024 1 $0 4 President & CEO, Director 04 Jan 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 03 Jan 2023 1 $0 4 President & CEO, Director 04 Jan 2023, 15:31
GLUE Monte Rosa Therapeutics, Inc. 01 Mar 2022 1 $0 4 President & CEO, Director 02 Mar 2022, 17:26
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 President & Chief Executive Officer Exhibit 24 - Power of Attorney, Director 23 Jun 2021, 20:38
GLUE Monte Rosa Therapeutics, Inc. 12 Apr 2021 2 $0 4 President & Chief Executive Officer, Director 25 Jun 2021, 17:00